{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4308, 
        4315
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4671, 
        4678
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4171, 
        4180
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4316, 
        4325
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4679, 
        4688
      ]
    }
  ], 
  "Comments Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7297, 
        7317
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7319, 
        7327
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4044, 
        4071
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4073, 
        4083
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4233, 
        4238
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4550, 
        4555
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7226, 
        7231
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7282, 
        7287
      ]
    }
  ], 
  "Lymphatic System Location (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4086, 
        4105
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4127, 
        4146
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7201, 
        7214
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        620, 
        649
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        651, 
        668
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3147, 
        3182
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        3184, 
        3196
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7145, 
        7171
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7173, 
        7191
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4147, 
        4180
      ]
    }
  ], 
  "Neoplasm Behaviour (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4160, 
        4170
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4299, 
        4307
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4662, 
        4670
      ]
    }
  ], 
  "Neoplasm Grade Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Ben,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4857, 
        4858
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4239, 
        4245
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7232, 
        7238
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7288, 
        7294
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4579, 
        4589
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7258, 
        7281
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3197, 
        3199
      ]
    }, 
    {
      "__agreement__": "", 
      "__annotator__": "Gemma", 
      "__extent": [
        3367, 
        3369
      ]
    }, 
    {
      "__agreement__": "FALSE POSITIVE", 
      "__annotator__": "Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        4083, 
        4085
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7193, 
        7200
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7218, 
        7225
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        7246, 
        7253
      ]
    }
  ], 
  "Supplementary Report Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": ",Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6467, 
        6499
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Gemma,Model - 20171102_22ABC_CDC_H3,Model - 20171123_CDC_B1B2_4,Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        6501, 
        6510
      ]
    }
  ], 
  "__text": "MSH|^~\\&|LABCORP-CORP|LABCORP^34D0655059^CLIA|Cancer Registry|State|201706010938|State006|ORU^R01|2017060107093839521000|P|2.3.1\nPID|1||^^^^SS^~11111111^^^^PI^|ALTERNATE ID|TEST^PATIENT^A||19500601|M||2054-5^Black or African American^CDC^^^|1234 Test Road^^ALBANY^NY^12201||^^^^^222^1234567|||||||\nNTE|1|L|A duplicate report has been generated due to demographic updates.\nORC|RE||111A1111111||||||||||||||||||Ordering Facility Name^^L|2222 W. Test Road^^Test^TX^77025|^^^^^111^1234567||\nOBR|1||111A1111111|^^^111111^Pathology Report^L|||201705301335|||||||20090115||Ordering Provider Name||||||20170530|||F|||||||\n\n\n\n\n\n\nPath report.gross observation\n\nGross description: The specimens are received in formalin, labeled with the patient's name and sublabeled as the following: (1) right SN #1; (2) right breast cancer; (3) right breast, new inferior lateral margin. \n (1) The specimen was previously received unfixed for frozen section  performed at Edmonds Center for Outpatient Surgery and consists  of a piece of fatty tissue (3.0 x 2.0 x 0.5 cm) containing one  lymph node. Section code: (A1) remaining tissue from frozen  section. (2) The specimen consists of an inked and sliced excision (5.0 cm SI,  6.5 cm ML, 2.0 cm AP) with no localization wire present. The  specimen is received serially sectioned LM into 9 slices with  a clip in slice #3. The tissue is fibrofatty and contains a  gray-white solid firm irregular mass (4.3 x 3.5 x 2.3 cm) within  slices #2-#7. The mass is 0.1 cm from the anterior, less than  0.1 cm from the posterior, 0.5 cm from the superior, less than  0.1 cm from the inferior, 0.1 cm from the lateral, and 1.5 cm  from the medial resection margins. No other nodules, masses or  lesions are identified. Ink code: purple-anterior; yellow-  posterior; black-superior; orange-inferior; blue-lateral; green-  medial. Section code: (B1) lateral resection margin,  perpendicularly sectioned, representative; (B2) slice #2,  representative; (B3) slice #3, representative; (B4) slice #4,  representative; (B5) slice #5, representative; (B6) slice #6,  representative; (B7) slice #7, representative; (B8) slice #8,  representative; (B9) medial resection margin, perpendicularly  sectioned, representative. (3) The specimen consists of a partially inked piece of breast  tissue (6.2 x 5.8 x 1.2 cm) with no overlying skin. No  localization wire is present. The breast tisssue is fibrofatty  and contains two gray-white solid firm irregular masses  (0.8 x 0.8 x 0.6 cm and 1.0 x 1.4 x 0.7 cm). Mass #1 is 0.5 cm  from the lateral resection margin and mass #2 is 0.1 cm from  the lateral resection margin. No other nodules, masses or  lesions are identified. Ink code: yellow-posterior; black-  superior; orange-inferior; blue-lateral. Section code: (C1-  C16) breast tissue, serially sectioned. Specimen entirely  submitted. \n Note: Approximate total fixation time in formalin for all specimens-30 hours and 30 minutes calculated using the collection date of 06/06/2017 with no collection time given. (JM:cmc16 705192) /IRI\n\n\nPayment procedure\n\nCPT                            .883311, 883291, 883071, 883072, 883073, W20062\n\n\nPath report.microscopic observation\n\nMicroscopic: A. An immunohistochemical stain for cytokeratin OSCAR was performed to evauate for isolated tumor cells and is NEGATIVE. A control stain showed appropriate reactivity. \n B. An immunohistochemical stain for cytokeratin OSCAR was performed to characterize the infiltrating carcinoma cells in relation to the margin in block B8. A control stain showed appropriate reactivity. \n * This test was developed and its performance characteristics determined by LabCorp. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. This test is used for clinical purposes. It should not be regarded as investigational or for research.\n\n\nPATHOLOGIST NAME\n\nElectronically signed: Pathologist name, Pathologist\n\n\nDiagnosis ICD code\n\nPathologist provided ICD-10:C50.911\n\n\nPath report.final diagnosis\n\nDiagnosis:A. Sentinel Lymph Node, #1, Excision:   One sentinel lymph node negative for metastatic carcinoma. Please   see CAP summary cancer data below. \n B-C. Right Breast Cancer, Excision And New Inferior Lateral Margin:    Invasive lobular carcinoma. Please see CAP summary cancer    data below. \n CAP CANCER CASE SUMMARY INVASIVE CARCINOMA OF THE BREAST: PROCEDURE: Excision without image-guided localization. LYMPH NODE SAMPLING: Sentinel lymph node. SPECIMEN LATERALITY: Right. TUMOR SITE: Position: 10 o'clock. TUMOR SIZE: 5.9 cm in maximum dimension. See comment. HISTOLOGIC TYPE: Invasive lobular carcinoma. HISTOLOGIC GRADE (Nottingham Histologic Score): Glandular/Tubular Differentiation: Score 3. Nuclear Pleomorphism: Score 2. Mitotic Rate: Score 1. Overall Grade: Grade 2. TUMOR FOCALITY: Single focus of invasive carcinoma. DUCTAL CARCINOMA IN SITU: No DCIS is present. LOBULAR CARCINOMA IN SITU: Present. MARGINS: Invasive Carcinoma: Margins positive for invasive carcinoma.  Anterior: Positive, 3 mm extent.  Posterior: Positive, 3 mm extent.  Superior: Carcinoma is 5 mm from margin.  Inferior: Carcinoma is less than 0.5 mm from new inferior margin.  Medial: Carcinoma is 2 mm from margin.  Lateral: Carcinoma is 0.5 mm from new lateral margin. DCIS: DCIS not present. \n LYMPH NODES: Total number of lymph nodes examined: 1. Number of sentinel lymph nodes examined: 1.  Number of lymph nodes with macrometastasis: 0.  Number of lymph nodes with micrometastasis: 0.  Number of lymph nodes with isolated tumor cells: 0. Method of evaluation of Sentinel lymph nodes: H&E, multiple levels and  immunohistochemistry. LYMPH-VASCULAR INVASION: Not identified. DERMAL LYMPH-VASCULAR INVASION: No skin present. PATHOLOGIC STAGING (AJCC, 7th ed., 2010): PRIMARY TUMOR: pT3. REGIONAL LYMPH NODES: pN0(i-)(sn). \n ADDITIONAL PATHOLOGIC FINDINGS: Fibrocystic-type changes and biopsy site changes are present. MICROCALCIFICATIONS: Present in invasive carcinoma and nonneoplastic tissue. ANCILLARY STUDIES: Biomarkers Performed Previously on Case: S17-46334 (CellNetix Pathology) Estrogen Receptor (ER) Status: Positive (98%), strong per report. Progesterone Receptor (PgR) Status: Positive (95%), moderate per report. Her-2: Negative for overexpression (score 1+) by immunohistochemistry,  per report. IRI/06/09/2017 **********************************************************************\n\n\nPath report.supplemental reports\n\nAddendum: TEST: ONCOYPE DX BREAST ASSAY RECURRENCE SCORE RESULT: 13 ER SCORE: 10.0 POSITIVE PR SCORE: 8.2 POSITIVE HER2 SCORE: 9.3 NEGATIVE *This test was developed and its performance characteristics determined by Genomic Health, Inc. It has not been cleared or approved by the FDA, nor is it currently required to be. The laboratory is regulated under CLIA as qualified to perform high-complexity testing. This test is used for clinical purposes. It should not be regarded as investigational or for research. Please see Genomic Health report OR000954447-01 for complete details. TIB/08/01/2017 Addendum Electronically Signed by Pathologist\n\n\nPath report.site of origin\n\nMaterial submitted: PART A: SENTINEL NODE #1 PART B: RIGHT BREAST CANCER PART C: NEW INFERIOR LATERAL MARGIN RIGHT BREAST\n\n\nPath report.comments\n\nComment:The lobular carcinoma forms dense nodules nearest the lateral margin and within the additional inferior lateral margin tissue. However, it extensively infiltrates in small groups and single cells through fibrous and adipose tissue involving a larger area than predicted by radiologic exam. The maximum dimension is calculated using a conservative estimate of the involvement of 7 of 9 slices (Medial-Lateral) in the excision added to a 9mm extent (M-L) in the additional tissue. The margin status for inferior and lateral margins reported in the CAP summary takes into account the additional tissue submitted.\n\n\n"
}